These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25960320)

  • 1. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.
    Deh K; Nguyen TD; Eskreis-Winkler S; Prince MR; Spincemaille P; Gauthier S; Kovanlikaya I; Zhang Y; Wang Y
    J Magn Reson Imaging; 2015 Dec; 42(6):1592-600. PubMed ID: 25960320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative susceptibility mapping across two clinical field strengths: Contrast-to-noise ratio enhancement at 1.5T.
    Ippoliti M; Adams LC; Winfried B; Hamm B; Spincemaille P; Wang Y; Makowski MR
    J Magn Reson Imaging; 2018 Nov; 48(5):1410-1420. PubMed ID: 29659131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing.
    Deh K; Kawaji K; Bulk M; Van Der Weerd L; Lind E; Spincemaille P; McCabe Gillen K; Van Auderkerke J; Wang Y; Nguyen TD
    Magn Reson Med; 2019 Feb; 81(2):1229-1236. PubMed ID: 30284727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
    Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
    J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.
    Eskreis-Winkler S; Zhou D; Liu T; Gupta A; Gauthier SA; Wang Y; Spincemaille P
    Magn Reson Imaging; 2017 Jan; 35():154-159. PubMed ID: 27587225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-centre, multi-vendor reproducibility of 7T QSM and R
    Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT
    Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.
    Spincemaille P; Liu Z; Zhang S; Kovanlikaya I; Ippoliti M; Makowski M; Watts R; de Rochefort L; Venkatraman V; Desmond P; Santin MD; Lehéricy S; Kopell BH; Péran P; Wang Y
    J Neuroimaging; 2019 Nov; 29(6):689-698. PubMed ID: 31379055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid automated liver quantitative susceptibility mapping.
    Jafari R; Sheth S; Spincemaille P; Nguyen TD; Prince MR; Wen Y; Guo Y; Deh K; Liu Z; Margolis D; Brittenham GM; Kierans AS; Wang Y
    J Magn Reson Imaging; 2019 Sep; 50(3):725-732. PubMed ID: 30637892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Susceptibility Mapping: MRI at 7T versus 3T.
    Spincemaille P; Anderson J; Wu G; Yang B; Fung M; Li K; Li S; Kovanlikaya I; Gupta A; Kelley D; Benhamo N; Wang Y
    J Neuroimaging; 2020 Jan; 30(1):65-75. PubMed ID: 31625646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping.
    Liu Z; Spincemaille P; Yao Y; Zhang Y; Wang Y
    Magn Reson Med; 2018 May; 79(5):2795-2803. PubMed ID: 29023982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
    Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
    Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-Minute Quantitative Susceptibility Mapping From Three-Dimensional Echo-Planar Imaging: Accuracy, Reliability, and Detection Performance in Patients With Cerebral Microbleeds.
    Wicaksono KP; Fushimi Y; Nakajima S; Yokota Y; Oshima S; Otani S; Sakurama A; Shima A; Sawamoto N; Okada T; Nakamoto Y
    Invest Radiol; 2021 Feb; 56(2):69-77. PubMed ID: 32649332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
    Zhang Y; Gauthier SA; Gupta A; Comunale J; Chia-Yi Chiang G; Zhou D; Chen W; Giambrone AE; Zhu W; Wang Y
    J Magn Reson Imaging; 2016 Aug; 44(2):426-32. PubMed ID: 26800367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feasibility of brain quantitative susceptibility mapping.
    Zhang S; Liu Z; Nguyen TD; Yao Y; Gillen KM; Spincemaille P; Kovanlikaya I; Gupta A; Wang Y
    Magn Reson Imaging; 2019 Jul; 60():44-51. PubMed ID: 30954651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisite reproducibility of quantitative susceptibility mapping and effective transverse relaxation rate in deep gray matter at 3 T using locally optimized sequences in 24 traveling heads.
    Naji N; Lauzon ML; Seres P; Stolz E; Frayne R; Lebel C; Beaulieu C; Wilman AH
    NMR Biomed; 2022 Nov; 35(11):e4788. PubMed ID: 35704837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-centre and multi-vendor reproducibility of a standardized protocol for quantitative susceptibility Mapping of the human brain at 3T.
    Lancione M; Bosco P; Costagli M; Nigri A; Aquino D; Carne I; Ferraro S; Giulietti G; Napolitano A; Palesi F; Pavone L; Pirastru A; Savini G; Tagliavini F; Bruzzone MG; Gandini Wheeler-Kingshott CAM; Tosetti M; Biagi L;
    Phys Med; 2022 Nov; 103():37-45. PubMed ID: 36219961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing intra- and inter-vendor reproducibility of T
    Lee Y; Callaghan MF; Acosta-Cabronero J; Lutti A; Nagy Z
    Magn Reson Med; 2019 Jan; 81(1):454-465. PubMed ID: 30159953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility.
    Hinoda T; Fushimi Y; Okada T; Fujimoto K; Liu C; Yamamoto A; Okada T; Kido A; Togashi K
    Invest Radiol; 2015 Aug; 50(8):522-30. PubMed ID: 25900085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.
    Zhang Y; Wei H; Sun Y; Cronin MJ; He N; Xu J; Zhou Y; Liu C
    J Magn Reson Imaging; 2018 Oct; 48(4):907-915. PubMed ID: 29380461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data-Driven Quantitative Susceptibility Mapping Using Loss Adaptive Dipole Inversion (LADI).
    Kamesh Iyer S; Moon BF; Josselyn N; Ruparel K; Roalf D; Song JW; Guiry S; Ware JB; Kurtz RM; Chawla S; Nabavizadeh SA; Witschey WR
    J Magn Reson Imaging; 2020 Sep; 52(3):823-835. PubMed ID: 32128914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.